CTMX Past Earnings image   This CTMX past earnings page last updated 5/10/2024
CTMX Past Earnings
PeriodPast Earnings DateGAAP
Q1 20245/8/20240.170
Q4 20233/11/20240.010
Q3 202311/7/20230.040
Q2 20238/8/2023-0.020
Q1 20235/9/2023-0.050
Q4 20223/27/2023-0.420
Q3 202211/8/2022-0.350
Q2 20228/4/2022-0.370
Q1 20225/5/2022-0.370
Q4 20213/1/2022-0.400
Q3 202111/4/2021-0.350
Q2 20218/5/2021-0.300
Q1 20215/6/2021-0.260
Q4 20202/24/2021-0.310
Q3 202011/5/2020-0.320
Q2 20208/6/2020-0.340
Q1 20205/7/20200.260
Q4 20192/27/2020-0.790
Q3 201911/7/2019-0.520
Q2 20198/7/2019-0.640
Q1 20195/9/2019-0.310
Q4 20182/27/2019-0.74
Q3 201811/6/2018-0.53
Q2 20188/8/2018-0.35
Q1 20185/9/2018-0.4
Q4 20173/7/20180.03
Q3 201711/7/2017-0.28
Q2 20178/7/2017-0.69
Q1 20175/5/2017-0.23
Q4 20163/2/2017-0.39
Q3 201611/3/2016-0.4
Q2 20168/3/2016-0.39
Q1 20165/6/2016-0.44
Q4 20153/7/2016-0.39
Q3 201511/23/2015-14.26
CTMX Past Revenue
PeriodPast Earnings DateGAAP
Q1 20245/8/20240.04B
Q4 20233/11/20240.03B
Q3 202311/7/20230.03B
Q2 20238/8/20230.02B
Q1 20235/9/20230.02B
Q4 20223/27/20230.00B
Q3 202211/8/20220.02B
Q2 20228/4/20220.02B
Q1 20225/5/20220.02B
Q4 20213/1/20220.02B
Q3 202111/4/20210.02B
Q2 20218/5/20210.02B
Q1 20215/6/20210.02B
Q4 20202/24/20210.02B
Q3 202011/5/20200.02B
Q2 20208/6/20200.02B
Q1 20205/7/20200.05B
Q4 20192/27/20200.01B
Q3 201911/7/20190.01B
Q2 20198/7/20190.01B
Q1 20195/9/20190.03B
Q4 20182/27/201911.47M
Q3 201811/6/201812.51M
Q2 20188/8/201821.34M
Q1 20185/9/201814.18M
Q4 20173/7/201827.07M
Q3 201711/7/201724.14M
Q2 20178/7/20178.75M
Q1 20175/5/201711.65M
Q4 20163/2/20176.27M
Q3 201611/3/20163.45M
Q2 20168/3/20163.09M
Q1 20165/6/20162.22M
Q4 20153/7/20161.99M
Q3 201511/23/20151.94M
Quotes delayed 20 minutes

Email EnvelopeFree CTMX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
CytomX Therapeutics (CTMX) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

CTSO Past Earnings
CTXR Past Earnings
CUE Past Earnings
CUTR Past Earnings
CVRX Past Earnings
CVS Past Earnings
CWBR Past Earnings
CYCC Past Earnings
CYCN Past Earnings
CYH Past Earnings

CTMX Past Earnings Q&A

What was the best and worst CTMX past earnings results?
For CytomX Therapeutics, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest CTMX past earnings result in our data set was 0.260/share posted in Q1 2020, while the lowest was in Q3 2015 when CTMX posted -14.26/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q1 2020 when CTMX reported 0.05B in revenue, while the quarter with the lowest revenue in our data set was Q4 2022 at 0.00B of revenue.

  Suggested answer: There are 35 CTMX past earnings results in our data set.

On this page we presented the CTMX past earnings date information for CytomX Therapeutics. Reviewing that CTMX Past Earnings for the company, we see that the highest past earnings result in our data set was in Q1 2020, when CTMX posted gaap of 0.260/share. Meanwhile the lowest CTMX past earnings result was in Q3 2015, when CTMX posted gaap of -14.26/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q1 2020 when CTMX reported 0.05B in revenue, while the smallest revenue quarter was Q4 2022 when CTMX reported 0.00B in revenue.

Any self directed investor doing their due diligence on CTMX or any other given stock can benefit from researching all of the CytomX Therapeutics past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate CytomX Therapeutics past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for CTMX. Thanks for visiting, and the next time you need to research CTMX past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: SRM shares outstanding history, NREF Stock Predictions, SNRH market cap history.


CTMX Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.